Tech Company Financing Transactions

BridgeBio Pharma Funding Round

KKR, Viking Global Investors and Aisling Capital joined a $135 million funding round for BridgeBio Pharma. This venture round closed on 9/14/2017.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

421 Kipling St.
Palo Alto, CA 94301
USA

Phone

(650) 391-9740

Website

www.bridgebio.com

Email Address

[email protected]

Overview

BridgeBio Pharma (Nasdaq: BBIO) is a collection of individuals focused on discovering and developing drugs for patients with grievous genetic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Neil Kumar

        

Browse more venture capital transactions:

Prev: 9/14/2017: OnCora Medical venture capital transaction
Next: 9/14/2017: Zembula venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary